Výsledky vyhledávání - "Antje Rinckleb"

Akademický článek

Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report

Autor: Arnulf Stenzl, Florian Battke, Martin Schulze, Maria Kopp, Maximilian Frick, Saskia Biskup, Carolin Blumendeller, Julius Boehme, Antje Rinckleb, Christina Kyzirakos, Simone Kayser, Sabine Kelkenberg, Natalia Pieper, Oliver Bartsch, Dirk Hadaschick

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)

Upper tract urothelial carcinoma (UTUC) is often diagnosed late and exhibits poor prognosis. Only limited data are available concerning therapeutic regimes and potential biomarkers for disease monitoring. Standard therapies often provide only insuffi

Externí odkaz: https://doaj.org/article/bd85689f6f1a40cea260be3acb8482f1

Zobrazit plný text záznamu

Autor: Natalia Pieper, Sabine Kelkenberg, Julius Boehme, Arnulf Stenzl, Martin Schulze, Antje Rinckleb, Oliver Bartsch, Florian Battke, Saskia Biskup, Simone Kayser, Christina Kyzirakos, Maximilian Frick, Dirk Hadaschick, Carolin Blumendeller, Maria Kopp

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)
Journal for Immunotherapy of Cancer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb0cd19c83062f8143bf6aed389cc486
https://jitc.bmj.com/content/9/1/e001406.full

Zobrazit plný text záznamu

A low-frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early-onset breast cancer (60 years) and is associated with reduced DNA repair capacity

Autor: Harald, Surowy, Dominic, Varga, Barbara, Burwinkel, Frederik, Marmé, Christof, Sohn, Manuel, Luedeke, Antje, Rinckleb, Christiane, Maier, Helmut, Deissler, Meta, Volcic, Lisa, Wiesmüller, Annette, Hasenburg, Maximilian, Klar, Josef, Hoegel, Walther, Vogel

Publikováno v: International journal of cancer. 142(4)

Only a fraction of breast cancer (BC) cases can be yet explained by mutations in genes or genomic variants discovered in linkage, genome-wide association and sequencing studies. The known genes entailing medium or high risk for BC are strongly enrich

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::97eed323813094dc0a3191d9e960f8f6
https://pubmed.ncbi.nlm.nih.gov/29044504

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání